Researchers discovered that chemotherapy can accidentally trigger a stress alarm in immune cells, causing inflammation that ...

Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...

Chemotherapy appears to activate a stress-sensing system inside immune cells. According to new research from Weill Cornell Medicine and Wake Forest ...

“Mind the Gap” is a safety warning, most familiarly on the London Underground via a recorded voice and signs, to alert ...

Blepharitis, a prevalent chronic inflammatory eye condition, impacts the eyelid margins and is classified as anterior or posterior blepharitis. Key market drivers include a growing patient pool, aging ...

The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.

Many people going through chemotherapy experience pain, tingling, or numbness in their hands and feet. This condition is ...

About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...

Chronic spinal stenosis affects millions of people worldwide, causing debilitating pain, numbness, and mobility limitations that can severely impact quality of life. This condition occurs when the ...